Last reviewed · How we verify

NCT04331431

Outcomes of the Intradural Extramedullary Tumors Resection

Completed NA Last updated 2 April 2020
What this trial tests

NA trial testing Spinal cord tumor resection in Spinal Cord Tumor in 24 participants. Completed in 8 April 2015.

Timeline
1 April 2008
Primary endpoint
1 April 2015
8 April 2015

Quick facts

Lead sponsorSohag University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment24
Start date1 April 2008
Primary completion1 April 2015
Estimated completion8 April 2015

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 28 to 66, any sex, with Spinal Cord Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The intradural extramedullary tumors remain curable diseases. Our aim in this study is to evaluate the postoperative status after the tumor resection and compare it to the preoperative status

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Tumor

Currently open trials in the same condition.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04331431.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing